A synthetic biology approach for consistent production of plant-made recombinant polyclonal antibodies against snake venom toxins

Plant Biotechnology Journal

Volumn 16, Issue 3, 2018, Pages 727-736

  Julve Parreño, Jose Manuel ^a   Huet, Estefanía ^a   Fernández del Carmen, Asun ^a   Segura, Alvaro ^b   Venturi, Micol ^a   Gandía, Antoni ^a   Pan, Wei Song ^a   Albaladejo, Irene ^a   Forment, Javier ^a   Pla, Davinia ^c   Wigdorovitz, Andrés ^d   Calvete, Juan J ^c   Gutiérrez, Carlos ^e   Gutiérrez, José María ^b   Granell, Antonio ^a   Orzáez, Diego ^a  

^a Universitat Politècnica de València   (Spain)

^b UNIVERSIDAD DE COSTA RICA   (Costa Rica)

^c INSTITUTO DE BIOMEDICINA DE VALENCIA   (Spain)

^d INSTITUTO NACIONAL DE TECNOLOGÍA AGROPECUARIA INTA   (Argentina)

^e UNIVERSITY OF LAS PALMAS DE GRAN CANARIA   (Spain)

Author keywords

molecular pharming; recombinant polyclonal antibodies; snake antivenoms

Indexed keywords

PLANTIBODY; SNAKE VENOM; VENOM ANTISERUM;

ANIMAL; ANTAGONISTS AND INHIBITORS; BOTHROPS; METABOLISM; PROCEDURES; SYNTHETIC BIOLOGY;

ANIMALS; ANTIVENINS; BOTHROPS; PLANTIBODIES; SNAKE VENOMS; SYNTHETIC BIOLOGY;

EID: 85030123782     PISSN: 14677644     EISSN: 14677652     Source Type: Journal    
DOI: 10.1111/pbi.12823     Document Type: Article

References (41)

1. Arnold, C. (2016) Synthetic biology tackles global antivenom shortage. Nature, 532, 292.
2. Beerli, R.R. and Rader, C. (2010) Mining human antibody repertoires. MAbs, 2, 365–378.
3. Bendandi, M., Marillonnet, S., Kandzia, R., Thieme, F., Nickstadt, A., Herz, S., Frode, R. et al. (2010) Rapid, high-yield production in plants of individualized idiotype vaccines for non-Hodgkin's lymphoma. Ann. Oncol. 21, 2420–2427.
4. Bolanos, R. (1972) Toxicity of Costa Rican snake venoms for the white mouse. Am. J. Trop. Med. Hyg. 21, 360–363.
5. Chippaux, J.P. (1998) Snake-bites: appraisal of the global situation. Bull. World Health Organ. 76, 515–524.
6. Elena, S.F., Bedhomme, S., Carrasco, P., Cuevas, J.M., de la Iglesia, F., Lafforgue, G., Lalic, J. et al. (2011) The evolutionary genetics of emerging plant RNA viruses. Mol. Plant Microbe Interact. 24, 287–293.
7. Frauches, T.S., Petretski, J.H., Arnholdt, A.C.V., Lasunskaia, E.B., de Carvalho, E.C.Q., Kipnis, T.L., da Silva, W.D. et al. (2013) Bothropic antivenom based on monoclonal antibodies, is it possible? Toxicon, 71, 49–56.
8. Gene, J.A., Roy, A., Rojas, G., Gutierrez, J.M. and Cerdas, L. (1989) Comparative study on coagulant, defibrinating, fibrinolytic and fibrinogenolytic activities of Costa Rican crotaline snake venoms and their neutralization by a polyvalent antivenom. Toxicon, 27, 841–848.
9. Graham, B.S. and Ambrosino, D.M. (2015) History of passive antibody administration for prevention and treatment of infectious diseases. Current Opin. HIV AIDS, 10, 129–134.
10. Gutierrez, J.M. (2014a) Current challenges for confronting the public health problem of snakebite envenoming in Central America. J. Venom Anim. Toxins Incl. Trop. Dis. 20, 7.
11. Gutierrez, J.M. (2014b) Reducing the impact of snakebite envenoming in Latin America and the Caribbean: achievements and challenges ahead. Trans. R. Soc. Trop. Med. Hyg. 108, 530–537.
12. Gutierrez, J.M., Gene, J.A., Rojas, G. and Cerdas, L. (1985) Neutralization of proteolytic and hemorrhagic activities of Costa Rican snake venoms by a polyvalent antivenom. Toxicon, 23, 887–893.
13. Gutierrez, J.M., Lomonte, B., Chaves, F., Moreno, E. and Cerdas, L. (1986) Pharmacological activities of a toxic phospholipase A isolated from the venom of the snake Bothrops asper. Comp. Biochem. Physiol. C, Comp. Pharmacol. Toxicol. 84, 159–164.
14. Gutierrez, J.M., Sanz, L., Escolano, J., Fernandez, J., Lomonte, B., Angulo, Y., Rucavado, A. et al. (2008) Snake venomics of the Lesser Antillean pit vipers Bothrops caribbaeus and Bothrops lanceolatus: correlation with toxicological activities and immunoreactivity of a heterologous antivenom. J. Proteome Res. 7, 4396–4408.
15. Gutierrez, J.M., Sanz, L., Flores-Diaz, M., Figueroa, L., Madrigal, M., Herrera, M., Villalta, M. et al. (2010) Impact of regional variation in Bothrops asper snake venom on the design of antivenoms: integrating antivenomics and neutralization approaches. J. Proteome Res. 9, 564–577.
16. Gutierrez, J.M., Leon, G. and Burnouf, T. (2011) Antivenoms for the treatment of snakebite envenomings: the road ahead. Biologicals, 39, 129–142.
17. Harrison, R.A., Hargreaves, A., Wagstaff, S.C., Faragher, B. and Lalloo, D.G. (2009) Snake envenoming: a disease of poverty. PLoS Negl. Trop Dis. 3, e569.
18. Julve, J.M., Gandia, A., Fernandez-Del-Carmen, A., Sarrion-Perdigones, A., Castelijns, B., Granell, A. and Orzaez, D. (2013) A coat-independent superinfection exclusion rapidly imposed in Nicotiana benthamiana cells by tobacco mosaic virus is not prevented by depletion of the movement protein. Plant Mol. Biol. 81, 553–564.
19. Laustsen, A.H. (2016) Snakebites: costing recombinant antivenoms. Nature, 538, 41.
20. Laustsen, A.H., Engmark, M., Milbo, C., Johannesen, J., Lomonte, B., Gutierrez, J.M. and Lohse, B. (2016) From fangs to pharmacology: the future of snakebite envenoming therapy. Curr. Pharm. Des. 22, 5270–5293.
21. Lavonas, E.J. (2012) Antivenoms for snakebite: design, function, and controversies. Curr. Pharm. Biotechnol. 13, 1980–1986.
22. Marillonnet, S., Giritch, A., Gils, M., Kandzia, R., Klimyuk, V. and Gleba, Y. (2004) In planta engineering of viral RNA replicons: Efficient assembly by recombination of DNA modules delivered by Agrobacterium. Proc. Natl. Acad. Sci. USA, 101, 6852–6857.
23. Marillonnet, S., Thoeringer, C., Kandzia, R., Klimyuk, V. and Gleba, Y. (2005) Systemic Agrobacterium tumefaciens-mediated transfection of viral replicons for efficient transient expression in plants. Nat. Biotechnol. 23, 718–723.
24. Paul, M. and Ma, J.K. (2011) Plant-made pharmaceuticals: leading products and production platforms. Biotechnol. Appl. Biochem. 58, 58–67.
25. Paul, M.J., Thangaraj, H. and Ma, J.K. (2015) Commercialization of new biotechnology: a systematic review of 16 commercial case studies in a novel manufacturing sector. Plant Biotechnol. J. 13, 1209–1220.
26. Pla, D., Gutierrez, J.M. and Calvete, J.J. (2012) Second generation snake antivenomics: comparing immunoaffinity and immunodepletion protocols. Toxicon, 60, 688–699.
27. Qiu, X., Wong, G., Audet, J., Bello, A., Fernando, L., Alimonti, J.B., Fausther-Bovendo, H. et al. (2014) Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp. Nature, 514, 47–53.
28. Ramos, H.R., Junqueira-de-Azevedo Ide, L., Novo, J.B., Castro, K., Duarte, C.G., Machado-de-Avila, R.A., Chavez-Olortegui, C. et al. (2016) A heterologous multiepitope DNA prime/recombinant protein boost immunisation strategy for the development of an antiserum against micrurus corallinus (Coral Snake) venom. PLoS Negl. Trop Dis. 10, e0004484.
29. Rasmussen, S.K., Naested, H., Muller, C., Tolstrup, A.B. and Frandsen, T.P. (2012) Recombinant antibody mixtures: production strategies and cost considerations. Arch. Biochem. Biophys. 526, 139–145.
30. Sarrion-Perdigones, A., Falconi, E.E., Zandalinas, S.I., Juarez, P., Fernandez-del-Carmen, A. and Granell, A. (2011) GoldenBraid: an iterative cloning system for standardized assembly of reusable genetic modules. PLoS ONE, 6, e21622.
31. Segura, A., Castillo, M.C., Nunez, V., Yarleque, A., Goncalves, L.R., Villalta, M., Bonilla, C. et al. (2010) Preclinical assessment of the neutralizing capacity of antivenoms produced in six Latin American countries against medically-relevant Bothrops snake venoms. Toxicon, 56, 980–989.
32. Soller, A. and Epstein, H.T. (1965) Biochemical and immunological aspects of the exclusion of lambda by superinfection with T4. Virology, 26, 715–726.
33. Stock, R.P., Massougbodji, A., Alagon, A. and Chippaux, J.P. (2007) Bringing antivenoms to Sub-Saharan Africa. Nat. Biotechnol. 25, 173–177.
34. Stoger, E., Sack, M., Fischer, R. and Christou, P. (2002) Plantibodies: applications, advantages and bottlenecks. Curr. Opin. Biotechnol. 13, 161–166.
35. Syller, J. (2012) Facilitative and antagonistic interactions between plant viruses in mixed infections. Mol. Plant Pathol. 13, 204–216.
36. Theakston, R.D. and Reid, H.A. (1983) Development of simple standard assay procedures for the characterization of snake venom. Bull. World Health Organ. 61, 949–956.
37. Walwyn, D.R., Huddy, S.M. and Rybicki, E.P. (2015) Techno-economic analysis of horseradish peroxidase production using a transient expression system in Nicotiana benthamiana. Appl. Biochem. Biotechnol. 175, 841–854.
38. Wang, W.J., Shih, C.H. and Huang, T.F. (2004) A novel P-I class metalloproteinase with broad substrate-cleaving activity, agkislysin, from Agkistrodon acutus venom. Biochem. Biophys. Res. Commun. 324, 224–230.
39. Wilensky, U. (1999) NetLogo. http://ccl.northwestern.edu/netlogo/.
40. Wilensky, U. (2007) NetLogo Hex Cell Aggregation model. http://ccl.northwestern.edu/netlogo/models/HexCellAggregation.
41. Zheng, Y., Zhao, L., Gao, J. and Fei, Z. (2011) iAssembler: a package for de novo assembly of Roche-454/Sanger transcriptome sequences. BMC Bioinform. 12, 453.